These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38641473)

  • 21. Corrigendum to "Liproxstatin-1 alleviates LPS/IL-13-induced bronchial epithelial cell injury and neutrophilic asthma in mice by inhibiting ferroptosis" [Int. Immunopharmacol. 109 (2022) 108770].
    Bao C; Liu C; Liu Q; Hua L; Hu J; Li Z; Xu S
    Int Immunopharmacol; 2023 Feb; 115():109482. PubMed ID: 36610897
    [No Abstract]   [Full Text] [Related]  

  • 22. Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
    Zhang Y; Ji T; Ma S; Wu W
    Int Immunopharmacol; 2023 Apr; 117():109865. PubMed ID: 36822094
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Salidroside postconditioning attenuates ferroptosis-mediated lung ischemia-reperfusion injury by activating the Nrf2/SLC7A11 signaling axis" [Int. Immunopharmacol. 115 (2023) 109731].
    Wang Y; Chen Z; Luo J; Zhang J; Sang AM; Cheng ZS; Li XY
    Int Immunopharmacol; 2023 Apr; 117():110002. PubMed ID: 36925352
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Paeonol derivative-6 attenuates inflammation by activating ZEB2 in acute liver injury" [Int. Immunopharmacol. 91 (2021) 107235].
    Yang J; Xu L; Wu M; Fang H; Lu Y; Shi C; Wang Y; Li Z; Zhang L; Zhang L
    Int Immunopharmacol; 2021 May; 94():107410. PubMed ID: 33578262
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to "Melatonin prevents endothelial dysfunction in SLE by activating the nuclear receptor retinoic acid-related orphan receptor-α" [Int. Immunopharmacol. 83 (2020) 106365].
    Huang H; Liu X; Chen D; Lu Y; Li J; Du F; Zhang C; Lu L
    Int Immunopharmacol; 2020 Sep; 86():106817. PubMed ID: 32736997
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to "The -172 A-to-G variation in ADAM17 gene promoter region affects EGR1/ADAM17 pathway and confers susceptibility to septic mortality with sepsis-3.0 criteria" [Int. Immunopharmacol. 102 (2022) 108385].
    He J; Zhao T; Liu L; Liao S; Yang S; Lu F; Hong Y; Wei N; Cheng H; Zhang W; Shao Y
    Int Immunopharmacol; 2023 Jun; 119():110285. PubMed ID: 37188605
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "Protective effect of arctiin against Toxoplasma gondii HSP70-induced allergic acute liver injury by disrupting the TLR4-mediated activation of cytosolic phospholipase A2 and platelet-activating factor" [Int. Immunopharmacol. 126 (2023) 111254].
    Lu JM; Xu X; Aosai F; Zhang MY; Zhou LL; Piao LX
    Int Immunopharmacol; 2024 Jan; 127():111422. PubMed ID: 38143162
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to "Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice" [Int. Immunopharmacol. 79 (2020) 106180].
    Cheng Y; Chen B; Xie W; Chen Z; Yang G; Cai Y; Shang H; Zhao W
    Int Immunopharmacol; 2020 Jul; 84():106461. PubMed ID: 32278662
    [No Abstract]   [Full Text] [Related]  

  • 29. Retraction notice to "LncRNA NEAT1 inhibition upregulates miR-16-5p to restrain the progression of sepsis-induced lung injury via suppressing BRD4 in amouse model" [Int. Immunopharmacol. 97 (2021) 107691].
    Yin J; Han B; Shen Y
    Int Immunopharmacol; 2023 Apr; 117():109855. PubMed ID: 36822093
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to "Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway" [Int. Immunopharmacol. 36 (2016) 132-141].
    Yao H; Hu C; Yin L; Tao X; Xu L; Qi Y; Han X; Xu Y; Zhao Y; Wang C; Peng J
    Int Immunopharmacol; 2019 Sep; 74():105786. PubMed ID: 31402320
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to "Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice" [Int. Immunopharmacol. 102 (2022) 108411].
    Hao J; Sun W; Xu H
    Int Immunopharmacol; 2022 Mar; 104():108550. PubMed ID: 35067473
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to "Mangiferin corrects the imbalance of Th17/Treg cells in mice with TNBS-induced colitis" [Int. Immunopharmacol. (2016) 220-228].
    Lim SM; Jeong JJ; Choi HS; Chang HB; Kim DH
    Int Immunopharmacol; 2016 Sep; 38():468. PubMed ID: 27262502
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "Berberine regulates PADI4-related macrophage function to prevent lung cancer" [Int. Immunopharmacol. 110 (2022) 108965].
    Gu W; Zhang M; Gao F; Niu Y; Sun L; Xia H; Li W; Zhang Y; Guo Z; Du G
    Int Immunopharmacol; 2023 Jul; 120():110366. PubMed ID: 37258402
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to "Epigallocatechin gallate potentially abrogates fluoride induced lung oxidative stress, inflammation via Nrf2/Keap1 signaling pathway in rats: An in-vivo and in-silico study" [Int. Immunopharmacol. 39 (2016) 128-139].
    Shanmugam T; Selvaraj M; Poomalai S
    Int Immunopharmacol; 2020 Mar; 80():106203. PubMed ID: 31983588
    [No Abstract]   [Full Text] [Related]  

  • 35. Corrigendum to "Laquinimod exerts anti-inflammatory and antiapoptotic effects in retinal ischemia/reperfusion injury" [Int. Immunopharmacol. 88 (2020) 106989].
    Jiang N; Li Z; Li Z; Zhang Y; Yu Z; Wan P; Zhu Y; Li Y; Su W; Zhuo Y
    Int Immunopharmacol; 2022 Jul; 108():108815. PubMed ID: 35534378
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to "Zerumbone enhances the Th1 response and ameliorates ovalbumin-induced Th2 responses and airway inflammation in mice" [Int. Immunopharmacol. 24 (2015) 383-391].
    Shieh YH; Huang HM; Ching-Chiung Wang ; Lee CC; Fan CK; Lee YL
    Int Immunopharmacol; 2017 Sep; 50():371. PubMed ID: 28751107
    [No Abstract]   [Full Text] [Related]  

  • 37. Retraction notice to "Long non-coding RNA NEAT1 plays an important role in sepsis-induced acute kidney injury by targeting miR-204 and modulating the NF-κB pathway" [Int. Immunopharmacol. 59 (2018) 252-260].
    Yi C; Jialing Q; Bin C; Youping L; Yulan C; Guojin X; Junming Q; Huasheng T; Dongxin J
    Int Immunopharmacol; 2021 Sep; 98():107710. PubMed ID: 34247982
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to "Sodium houttuyfonate enhances the intestinal barrier and attenuates inflammation induced by Salmonella typhimurium through the NF-κB pathway in mice" [Int. Immunopharmacol. 89 (2020) 107058].
    Zhang L; Lv H; Li Y; Dong N; Bi C; Shan A; Wu Z; Shi B
    Int Immunopharmacol; 2021 Mar; 92():107351. PubMed ID: 33444920
    [No Abstract]   [Full Text] [Related]  

  • 39. Corrigendum to "Protective effect of tormentic acid from Potentilla chinensis against lipopolysaccharide/D-galactosamine induced fulminant hepatic failure in mice" [Int. Immunopharmacol. 19 (2014) 365-372].
    Lin X; Zhang S; Huang R; Tan S; Liang S; Wu X; Zhuo L; Huang Q
    Int Immunopharmacol; 2021 Jan; 90():107244. PubMed ID: 33309532
    [No Abstract]   [Full Text] [Related]  

  • 40. Corrigendum to "HMGB1-TLR4-IL-23-IL-17A axis accelerates renal ischemia-reperfusion injury via the recruitment and migration of neutrophils" [Int. Immunopharmacol. 94 (2021) 107433].
    Zhang J; Li Q; Zou YR; Wu SK; Lu XH; Li GS; Wang J
    Int Immunopharmacol; 2022 Mar; 104():108461. PubMed ID: 34991980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.